Molecular Analysis of the ERGIC-53 Gene in 35 Families With Combined Factor V-Factor VIII Deficiency

• Published in: Blood Vol. 93; no. 7; pp. 2253 - 2260
• Main Authors: Neerman-Arbez, M., Johnson, K.M., Morris, M.A., McVey, J.H., Peyvandi, F., Nichols, W.C., Ginsburg, D., Rossier, C., Antonarakis, S.E., Tuddenham, E.G.D.
• Format: Journal Article
• Language: English
• Published: Washington, DC Elsevier Inc 01.04.1999; The Americain Society of Hematology
• Subjects: Algeria - ethnology; Alleles; Biological and medical sciences; China - ethnology; Codon - genetics; Consanguinity; DNA Mutational Analysis; Ethnicity - genetics; Factor V Deficiency - complications; Factor V Deficiency - ethnology; Factor V Deficiency - genetics; Female; Genes, Recessive; Haplotypes; Hematologic and hematopoietic diseases; Hemophilia A - complications; Hemophilia A - ethnology; Hemophilia A - genetics; Humans; Iran - ethnology; Italy - ethnology; Jews - genetics; Male; Mannose-Binding Lectins; Medical sciences; Membrane Proteins - deficiency; Membrane Proteins - genetics; Mutation; Pakistan - ethnology; Platelet diseases and coagulopathies; Polymorphism, Single-Stranded Conformational; South Africa - ethnology; United Kingdom - ethnology; Pakistan; Iran; China; Italy; South Africa; United Kingdom; Algeria; Human; Genetic variability; Family study; Pathogenesis; Deficiency; Factor VIII; Hemopathy; Genetic disease; Factor V; Gene; Mixed; Genetics; Mutation; Coagulation factor; Coagulopathy; Polymorphism
• ISSN: 0006-4971; 1528-0020
• DOI: 10.1182/blood.V93.7.2253

Combined factor V-factor VIII deficiency (F5F8D) is a rare, autosomal recessive coagulation disorder in which the levels of both coagulation factors V and VIII are diminished. The F5F8D locus was previously mapped to a 1-cM interval on chromosome 18q21. Mutations in a candidate gene in this region, ERGIC-53, were recently found to be associated with the coagulation defect in nine Jewish families. We performed single-strand conformation and sequence analysis of the ERGIC-53 gene in 35 F5F8D families of different ethnic origins. We identified 13 distinct mutations accounting for 52 of 70 mutant alleles. These were 3 splice site mutations, 6 insertions and deletions resulting in translational frameshifts, 3 nonsense codons, and elimination of the translation initiation codon. These mutations are predicted to result in synthesis of either a truncated protein product or no protein at all. This study revealed that F5F8D shows extensive allelic heterogeneity and all ERGIC-53 mutations resulting in F5F8D are “null.” Approximately 26% of the mutations have not been identified, suggesting that lesions in regulatory elements or severe abnormalities within the introns may be responsible for the disease in these individuals. In two such families, ERGIC-53 protein was detectable at normal levels in patients' lymphocytes, raising the further possibility of defects at other genetic loci.